Protein kinase Akt activity in human thyroid tumors

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The phosphatidylinositol-3-kinase (PI3K)/Akt signaling pathway is crucial in cell growth and survival.
• Dysregulation of Akt is implicated in various cancers, including thyroid malignancies.
• Understanding Akt expression and activation in thyroid tumors is essential for potential therapeutic strategies.

Purpose of the Study:

• To examine the expression and activation levels of Akt protein kinase (Akt1/2/3) in normal thyroid tissues and various human thyroid tumors.
• To investigate the correlation between Akt activity, tumor proliferation, and apoptosis in thyroid tissues.
• To explore potential mechanisms of PI3K/Akt pathway inhibition in thyroid tumorigenesis.

Main Methods:

• Immunohistochemistry and Western blotting were used to assess Akt protein expression and phosphorylation (activation).
• Analysis included conventionally normal thyroid tissues, benign (follicular adenoma), and highly differentiated malignant (papillary and follicular carcinomas) thyroid tumors.
• Quantification of Akt isoforms (Akt1, Akt2, Akt3) and their activity markers (e.g., Thr308 phosphorylation) was performed.

Main Results:

• Akt1 expression differed between tumor and normal tissues in papillary carcinomas and multinodular goiter.
• Follicular adenomas showed significantly lower Akt expression in both tumor and normal tissues compared to follicular carcinoma.
• Total Akt activity was reduced in tumors versus normal tissues, and Akt activity did not correlate with proliferation or apoptosis levels.

Conclusions:

• Akt expression and activity patterns vary distinctly among different thyroid tumor types and normal tissues.
• Akt activation, specifically via Thr308 phosphorylation, is not directly linked to proliferative activity in thyroid tumors.
• The study suggests potential inhibitory mechanisms of the PI3K/Akt pathway in thyroid tumors warrant further investigation.